Moreover, iCAFs could specifically generate CXCL12 to interact with tumor-infiltrating myeloid cells through the activation of the CXCL12/CXCR4 axis to induce the M2 polarization of macrophages or restrain the antigen presentation of cDCs to suppress antitumor immunity. Here, CXCL12 is linked to neoplasm.